Several programs offer continuing medical education (CME) credit
Fibrodysplasia ossificans progressiva (FOP) is one of the more than 7,000 rare diseases in the world. Health care providers simply cannot be familiar with every rare disease. We are pleased to connect you to FOP awareness and education programs that you can participate in online. Some of these programs offer continuing medical education (CME) credit.
These programs have been developed and sponsored by other organizations or companies with content provided by FOP experts. You will find the developer and sponsor of each program in the listing below.
Springer Healthcare IME
FOP Recognition, Treatment and Hope
Springer Healthcare IME is currently offering an educational series with videos, publications, diagnosis and care tools, and a webinar which features an FOP family. This educational series is supported by an educational grant from Ipsen.
Springer Healthcare IME — in collaboration with a global network of scientific experts — designs, develops and delivers meaningful education that inspires healthcare professionals to maximize their learning and make measurable change in their own clinical practice.
Access the FOP Clinical Diagnosis Quiz
Access the "Tin Soldiers Global CME Series on FOP"
The Tin Soldiers FOP Outreach Program is offering the Global CME Series on FOP, a seven-part video series, for licensed health care professionals. Each session includes a talk by an FOP expert physician. The Series is accredited with the Health Professions Council of South Africa.
Watch this short video to learn more about the FOP clinical experts and the topics they cover in the Global CME Series on FOP.
Access the FOP Treatment Guidelines
The FOP Treatment Guidelines, authored by the International Clinical Council on FOP, contain detailed medical information and guidelines on the symptomatic management of FOP. In order to continually provide updated guidelines with rapid access to physicians treating FOP patients worldwide, multiple simultaneous translations are not presently feasible. To ensure the widest distribution, guidelines are written in English and are accessible to physicians worldwide.
We emphasize that this report reflects the authors' experience and opinions on the various classes of symptom-modifying medications and is meant only as a guide to this controversial area of therapeutics. Although there are common physical features shared by every person who has FOP, differences among individuals may alter the potential benefits or risks of any medication or class of medications discussed here. The decision to use or withhold a particular medication must ultimately rest with an individual patient and his or her physician.